Han Biomedical (ROCO:6999) Gross-Profit-to-Asset % : 29.40% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Han Biomedical Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Han Biomedical's annualized Gross Profit for the quarter that ended in Jun. 2024 was NT$73.3 Mil. Han Biomedical's average Total Assets over the quarter that ended in Jun. 2024 was NT$249.3 Mil. Therefore, Han Biomedical's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 29.40%.

Han Biomedical Gross-Profit-to-Asset % Historical Data

The historical data trend for Han Biomedical's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Han Biomedical Gross-Profit-to-Asset % Chart

Han Biomedical Annual Data

Trend

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

26.44

29.68

31.90

Han Biomedical Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
Gross-Profit-to-Asset %	-	-	28.02	35.49	29.40

Competitive Comparison of Han Biomedical's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Han Biomedical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Han Biomedical's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Han Biomedical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Han Biomedical's Gross-Profit-to-Asset % falls into.

Han Biomedical Gross-Profit-to-Asset % Calculation

Han Biomedical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	70.458	/	( (212.221	+	229.503)	/ 2 )
	=	70.458	/	220.862
	=	31.90 %

Han Biomedical's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	73.28	/	( (229.503	+	269.052)	/ 2 )
	=	73.28	/	249.2775
	=	29.40 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Han Biomedical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Han Biomedical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Han Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Han Biomedical Inc (ROCO:6999) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN

Website

https://www.hanbiomedical.com

Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.

Han Biomedical Headlines

No Headlines